Lipo-C Peptide: What It Actually Is, Ingredients, Dosing & Evidence
Lipo-C is sold across med spas, weight-loss clinics, and peptide telehealth catalogs as a fat-burning injection, and it is routinely labeled a peptide. It is not one. Lipo-C is a lipotropic blend of methionine, inositol, choline, L-carnitine, and B vitamins, and none of those ingredients is a peptide. That naming problem matters, because it puts a nutrient injection with thin outcome evidence in the same mental category as compounds that have actual trial data behind them. This guide covers what is in the vial, how clinics dose it, what the research does and does not support, and what it costs as of July 2026.
What Lipo-C Actually Is (And Why It Is Not a Peptide)
A peptide is a short chain of amino acids joined by peptide bonds. BPC-157 is 15 amino acids. Semaglutide is a 31-amino-acid GLP-1 analog. Lipo-C contains one amino acid, methionine, plus compounds that are not amino acids at all. Choline and inositol are vitamin-like nutrients. L-carnitine is a quaternary ammonium compound synthesized from lysine and methionine, not a peptide. B12 is a cobalt-containing vitamin.
The label sticks because of distribution, not chemistry. The same 503A compounding pharmacies and telehealth platforms that ship genuine peptides also ship lipotropics, and their catalogs list them side by side. If you are trying to understand what separates the two categories, our what are peptides primer and the peptide supplements guide draw the line more carefully than most vendor pages do.
Practical consequence: do not transfer your expectations from peptide research onto Lipo-C. The evidence bases are not comparable, and they are not close.
What Is in a Lipo-C Injection?
There is no single Lipo-C formula. Each compounding pharmacy sets its own, so concentrations differ and the ingredient list differs. The pattern across most formulations:
| Ingredient | What it is | Stated rationale |
|---|---|---|
| Methionine | Essential sulfur-containing amino acid | Methyl donor via SAMe; supports hepatic fatty-acid handling |
| Inositol | Carbocyclic sugar, vitamin-like | Insulin signaling and lipid transport in liver cells |
| Choline | Essential nutrient | Phosphatidylcholine synthesis and VLDL export from the liver |
| L-carnitine | Quaternary ammonium compound | Shuttles long-chain fatty acids into mitochondria |
| Vitamin B12 | Cyanocobalamin or methylcobalamin | Energy metabolism, red cell production, methylation |
| B1, B5, B6 (variable) | Thiamine, dexpanthenol, pyridoxine | Cofactors in carbohydrate and fat metabolism |
| Lidocaine (variable) | Local anesthetic | Reduces injection sting only; no metabolic role |
Ask any clinic for the exact strengths in mg/mL before you buy a package. Two products both named Lipo-C can differ enough that comparing prices without comparing concentrations is meaningless. The same problem shows up across compounded peptide products generally.
How Lipo-C Is Supposed to Work
The mechanistic story is real biochemistry. Choline deficiency impairs the liver's ability to export triglycerides as VLDL particles and is an established cause of hepatic steatosis. Methionine feeds one-carbon metabolism and SAMe production. Carnitine is genuinely required to transport long-chain fatty acids across the inner mitochondrial membrane for beta-oxidation. Inositol has a plausible role in insulin signaling, and oral myo-inositol has been studied in PCOS for insulin sensitivity.
The gap is between mechanism and outcome. Each of these nutrients is necessary for fat metabolism, and that is not the same as saying more of it accelerates fat loss in someone who is already replete. A cofactor at sufficiency does not become a rate-limiting lever just because you inject more of it. This is the same reasoning error that inflates expectations around GLP-1 supplements and GLP-1 boosters.
Where Lipo-C could plausibly do something is in a person with an actual deficiency, most realistically B12. Correcting a genuine B12 deficiency will improve fatigue. That is treating a deficiency, not burning fat.
What the Evidence Actually Shows
No published randomized controlled trial has tested the injectable methionine-inositol-choline-carnitine-B-vitamin combination for weight loss. That is the central fact about Lipo-C, and vendor pages tend to route around it by citing mechanism papers on individual nutrients instead.
On the strongest single component: a 2016 meta-analysis of 9 randomized trials of oral L-carnitine reported about 1.33 kg greater weight loss than control, and a larger 2020 meta-analysis of 37 trials reported roughly 1.21 kg. Both note the effect is small and attenuates over time. Neither used injections, and neither tested the Lipo-C combination.
For calibration, semaglutide 2.4 mg produced roughly 15% mean body-weight reduction over 68 weeks in STEP 1, and tirzepatide reached higher figures in SURMOUNT-1. The gap between roughly 1 kg from a single oral nutrient and 15% of body weight from a GLP-1 is not a matter of degree. See GLP-1 for weight loss and semaglutide vs tirzepatide for the trial numbers.
Reported Lipo-C before-and-after results almost always come from patients who were simultaneously in a supervised calorie deficit, on a GLP-1, or both. Attributing that outcome to the injection is a straightforward attribution error.
Lipo-C Dosing and Injection Schedule
Because Lipo-C is compounded rather than FDA-approved, there is no official dosing label. Clinic protocols cluster around:
- Frequency: once or twice weekly is the most common; some programs run daily or every-other-day blocks for two to four weeks
- Volume: typically 1 mL per injection
- Route: intramuscular into the deltoid or gluteal muscle, or subcutaneous into abdominal fat depending on the formula and clinic preference
- Storage: refrigerated, protected from light; B12-containing formulas are light-sensitive
- Duration: programs are usually sold in 4, 8, or 12-week packages
Lipo-C ships as a premixed solution, not a lyophilized powder, so there is no reconstitution step. If you are used to reconstituting genuine peptides, our guide to reconstituting peptides does not apply here.
Rotate injection sites. Methionine-containing lipotropics sting, and repeated injection into the same spot produces induration and bruising.
Lipo-C Side Effects and Who Should Avoid It
At nutritional doses the ingredients are generally well tolerated. Reported complaints are mostly local and mild:
- Injection-site pain, stinging, redness, bruising, or a firm lump
- A sulfurous or metallic taste and a distinctive urine odor from methionine
- Transient nausea, loose stools, or stomach upset
- Flushing or a brief warm sensation shortly after injection
- Fishy body odor at higher choline exposures, from trimethylamine production
- Headache, and occasionally insomnia when injected late in the day
The larger risk is not pharmacologic. It is sterility and oversight. Compounded injectables are not FDA-reviewed for safety, effectiveness, or quality, and a non-sterile injectable introduces contamination directly into tissue. Verify that the pharmacy supplying the product holds the licensure required for sterile compounding, and that a licensed clinician is actually reviewing your case rather than rubber-stamping an intake form. A July 2026 JAMA Health Forum secret-shopper study of 75 weight-loss businesses in West Virginia and Oklahoma found some supplying pharmacies lacked sterile-compounding licensure or had prior disciplinary history, which is the relevant failure mode for any injectable sold this way.
Avoid or get physician clearance first if you have significant liver or kidney disease, are pregnant or breastfeeding, have a seizure disorder, have a cobalt or cobalamin allergy, or have a methionine metabolism disorder such as homocystinuria. If you are on a GLP-1 and already experiencing side effects, adding a second injectable makes attribution harder; see GLP-1 side effects.
Lipo-C Cost as of July 2026
Lipo-C is cash-pay. Insurance does not cover it. Advertised pricing as of July 2026:
- Single in-office injection: commonly $15 to $75, with $20 to $75 the usual med-spa range
- Multi-shot packages: bundles of 4 to 10 shots reduce the per-injection price, sometimes to the $12 to $25 range
- Monthly programs: roughly $80 to $300 per month depending on injection frequency and market
Two cost traps. First, per-shot pricing tells you nothing without concentrations, so a $25 injection can contain less active material than a $20 one. Second, Lipo-C is frequently bundled as an upsell onto a GLP-1 program, which inflates the total monthly spend without adding measurable outcome. If your budget is fixed, spending it on the GLP-1 rather than the add-on is the better-supported allocation. Compare against semaglutide pricing and tirzepatide cost.
Prices above are ranges observed in advertised clinic and telehealth pricing as of July 2026 and vary by location and provider.
Lipo-C vs GLP-1 Medications
These are different classes of intervention with different evidence tiers, and it is worth being blunt about the asymmetry.
| Lipo-C | Semaglutide / tirzepatide | |
|---|---|---|
| Mechanism | Nutrient cofactors in fat metabolism | Incretin receptor agonism; appetite and gastric emptying |
| Phase 3 trial data | None for the combination | STEP and SURMOUNT programs |
| Typical weight change | Not established independent of diet | Roughly 15% at 68 weeks for semaglutide 2.4 mg |
| FDA-approved version | No | Yes (Wegovy, Zepbound) |
| Side-effect burden | Low, mostly local | Meaningful GI burden during escalation |
A defensible use of Lipo-C is as an adjunct someone tolerates well and can afford, with expectations set at roughly zero independent weight effect. An indefensible use is substituting it for a GLP-1 because it is cheaper or sounds gentler. If cost is the barrier, look at GLP-1 microdosing and telehealth price comparison before downgrading to a nutrient injection.
Lipo-C vs Actual Fat-Loss Peptides
If the appeal of Lipo-C is that it is marketed as a peptide, it is worth seeing what the genuine peptides in that space look like, because their evidence is also thinner than vendor copy suggests. AOD-9604 is a growth-hormone fragment that failed to beat placebo on weight loss in its phase 2 program. MOTS-c has interesting mitochondrial mechanism work and essentially no human outcome data. Tesamorelin has real trial data, but for visceral fat in HIV-associated lipodystrophy, not general weight loss.
The broader map is in peptides for weight loss and peptides for fat loss. The short version: incretins have the data, everything else in this category is promissory.
The B12 Overlap With Compounded GLP-1 Formulas
This is the practical detail most Lipo-C pages miss. Many compounded semaglutide products already contain vitamin B12, and B-vitamin additives are the norm rather than the exception. The July 2026 JAMA Health Forum secret-shopper study of 75 clinics and med spas found additive-containing compounded formulations in 58.7% of cases, with B vitamins the most common additive at 56.0%.
So if you are on compounded semaglutide with B12 and you add a B12-containing Lipo-C shot, you are paying twice for the same ingredient. B12 is water-soluble and the excess is excreted, so this is a waste of money rather than a safety problem, but it is worth catching. Ask both providers for the full formulation before stacking.
Related reading: NAD+ injections, HCG injections, and peptides for energy cover the other injectables commonly bundled into the same weight-loss programs.
Is Lipo-C Worth It?
Honest read: Lipo-C is a low-risk, low-evidence adjunct sold at a price that is easy to justify per shot and harder to justify per outcome. It is not a peptide, it has no trial data as a combination, and the most defensible benefit it offers is correcting a B12 deficiency in someone who actually has one, which a standalone B12 shot does more cheaply.
Reasonable to try if: you tolerate injections, you have discretionary budget after your primary treatment, you understand the weight effect is unproven, and your provider has confirmed the sterility and licensure chain.
Skip it if: it is being sold to you as an alternative to a GLP-1, it is bundled into a program you cannot itemize, the clinic cannot tell you the mg/mL of each ingredient, or the pitch leans on the word peptide. That last one tells you something about how carefully the rest of the program was assembled.
Frequently Asked Questions About Lipo-C
No. Lipo-C is a lipotropic injection built from amino acids, B vitamins, and vitamin-like nutrients: methionine, inositol, choline, L-carnitine, and usually cyanocobalamin or methylcobalamin (B12). Methionine is a single amino acid, not a chain of them, so it does not meet the definition of a peptide. Inositol and choline are nutrients, not amino acids at all. The word peptide gets attached to Lipo-C mostly because compounding pharmacies and telehealth clinics list it in the same catalog as genuine peptides such as BPC-157 or CJC-1295.
The core is methionine, inositol, and choline, commonly abbreviated MIC. Most Lipo-C formulas add L-carnitine and vitamin B12, and some add thiamine (B1), pyridoxine (B6), dexpanthenol (B5), or lidocaine to reduce injection sting. There is no standardized Lipo-C formula. Concentrations and the exact ingredient list vary by compounding pharmacy, which is why two products with the same name can differ substantially.
There is no published randomized controlled trial testing the injectable MIC plus carnitine plus B-vitamin combination for weight loss. Evidence for individual components is modest and comes mostly from oral supplementation. A 2016 meta-analysis of 9 randomized trials of oral L-carnitine found about 1.33 kg more weight lost than control, and a larger 2020 meta-analysis of 37 trials found roughly 1.21 kg, with the effect shrinking over time. That is a small effect from a different route of administration. Any dramatic before-and-after result attributed to Lipo-C is almost certainly driven by the calorie deficit, coaching, or GLP-1 medication prescribed alongside it.
Clinic protocols are typically once or twice weekly intramuscularly or subcutaneously, most often 1 mL per dose. Some medical spas run daily or every-other-day schedules during a short promotional block. Because Lipo-C is compounded rather than FDA-approved, there is no official dosing label; the schedule is set by the prescribing clinic and varies widely.
As of July 2026, single Lipo-C or lipotropic injections are commonly advertised in the $15 to $75 per shot range, with $20 to $75 typical at med spas and weight-loss clinics. Multi-shot packages and at-home kits bring the per-shot price down, and monthly programs are commonly quoted between roughly $80 and $300 depending on injection frequency and location. Prices vary widely by clinic and are not covered by insurance.
The individual nutrients have long safety records at nutritional doses, and the most common complaints are injection-site pain, bruising, a metallic or urine-odor effect from methionine, transient nausea, and mild diarrhea. The meaningful risk is not the ingredients but the sterility of the product and the qualifications of whoever injects it. Compounded injectables are not FDA-reviewed for safety, effectiveness, or quality, and non-sterile preparation of an injectable carries infection risk. People with liver or kidney disease, pregnancy, or a history of seizure disorder should not use it without a physician review.
Skinny shot is a marketing name that usually refers to a lipotropic MIC or MIC-B12 injection, so in practice it often is the same category of product as Lipo-C. A plain B12 shot is different and much simpler: it is cyanocobalamin or methylcobalamin alone, without the methionine, inositol, choline, or carnitine. If a clinic sells you a skinny shot, ask for the exact ingredient list and concentrations rather than relying on the brand name.
They are not comparable in effect size. Semaglutide 2.4 mg produced roughly 15% mean body-weight reduction over 68 weeks in the STEP 1 trial; there is no trial evidence that Lipo-C produces clinically significant weight loss on its own. Lipo-C is sometimes added alongside a GLP-1, which is where the B12 overlap becomes relevant, since many compounded semaglutide formulas already include B12. If the goal is meaningful weight loss, the GLP-1 is doing the work.
Two reasons. B12 is genuinely involved in energy metabolism and red blood cell production, and deficiency causes fatigue, so correcting a real deficiency helps. The second reason is commercial: B12 gives the injection a perceptible energy narrative and differentiates one clinic formula from another. Adding B12 to a patient who is not deficient does not create extra weight loss. Excess is excreted.
No, not legitimately. Lipo-C is a compounded prescription injectable and requires a prescriber and a licensed compounding pharmacy. Products sold as research-use-only Lipo-C without a prescription are outside that chain and carry both sterility and identity risk, since you have no verification of what is actually in the vial.
This page is informational and is not medical advice. Lipo-C is a compounded preparation; compounded medications are not FDA-approved or reviewed for safety, effectiveness, or quality. Pricing ranges reflect advertised clinic and telehealth pricing as of July 2026 and vary by provider and location. Discuss any injectable with a licensed clinician before use.